187 related articles for article (PubMed ID: 37327589)
1. YY2/PHGDH axis suppresses tumorigenesis by inhibiting tumor cell de novo serine biosynthesis.
Li J; Luo X; Wei M; Li Z; Li Y; Zhao H; Miyagishi M; Kasim V; Wu S
Biomed Pharmacother; 2023 Sep; 165():115006. PubMed ID: 37327589
[TBL] [Abstract][Full Text] [Related]
2. Homeostasis Imbalance of YY2 and YY1 Promotes Tumor Growth by Manipulating Ferroptosis.
Li Y; Li J; Li Z; Wei M; Zhao H; Miyagishi M; Wu S; Kasim V
Adv Sci (Weinh); 2022 May; 9(13):e2104836. PubMed ID: 35246964
[TBL] [Abstract][Full Text] [Related]
3. YY2-DRP1 Axis Regulates Mitochondrial Fission and Determines Cancer Stem Cell Asymmetric Division.
Wei M; Nurjanah U; Li J; Luo X; Hosea R; Li Y; Zeng J; Duan W; Song G; Miyagishi M; Kasim V; Wu S
Adv Sci (Weinh); 2023 Aug; 10(23):e2207349. PubMed ID: 37300334
[TBL] [Abstract][Full Text] [Related]
4. Metabolic shift to serine biosynthesis through 3-PG accumulation and PHGDH induction promotes tumor growth in pancreatic cancer.
Itoyama R; Yasuda-Yoshihara N; Kitamura F; Yasuda T; Bu L; Yonemura A; Uchihara T; Arima K; Hu X; Jun Z; Okamoto Y; Akiyama T; Yamashita K; Nakao Y; Yusa T; Kitano Y; Higashi T; Miyata T; Imai K; Hayashi H; Yamashita YI; Mikawa T; Kondoh H; Baba H; Ishimoto T
Cancer Lett; 2021 Dec; 523():29-42. PubMed ID: 34508795
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor Yin Yang 2 is a novel regulator of the p53/p21 axis.
Kasim V; Xie YD; Wang HM; Huang C; Yan XS; Nian WQ; Zheng XD; Miyagishi M; Wu SR
Oncotarget; 2017 Aug; 8(33):54694-54707. PubMed ID: 28903375
[TBL] [Abstract][Full Text] [Related]
6. p53 Protein-mediated regulation of phosphoglycerate dehydrogenase (PHGDH) is crucial for the apoptotic response upon serine starvation.
Ou Y; Wang SJ; Jiang L; Zheng B; Gu W
J Biol Chem; 2015 Jan; 290(1):457-66. PubMed ID: 25404730
[TBL] [Abstract][Full Text] [Related]
7. Non-canonical phosphoglycerate dehydrogenase activity promotes liver cancer growth via mitochondrial translation and respiratory metabolism.
Shu Y; Hao Y; Feng J; Liu H; Li ST; Feng J; Jiang Z; Ye L; Zhou Y; Sun Y; Zhou Z; Wei H; Gao P; Zhang H; Sun L
EMBO J; 2022 Dec; 41(23):e111550. PubMed ID: 36314841
[TBL] [Abstract][Full Text] [Related]
8. Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E.
Ma X; Li B; Liu J; Fu Y; Luo Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):66. PubMed ID: 30744688
[TBL] [Abstract][Full Text] [Related]
9. ZEB1 Transcriptionally Activates PHGDH to Facilitate Carcinogenesis and Progression of HCC.
Wang H; Lin F; Xu Z; Yu S; Li G; Liao S; Zhao W; Zhang F; Wang J; Wang S; Ouyang C; Zhang C; Xia H; Wu Y; Jiang B; Li Q
Cell Mol Gastroenterol Hepatol; 2023; 16(4):541-556. PubMed ID: 37331567
[TBL] [Abstract][Full Text] [Related]
10. Multi-omics Analysis of the Role of PHGDH in Colon Cancer.
Dai Z; Chen L; Pan K; Zhao X; Xu W; Du J; Xing C
Technol Cancer Res Treat; 2023; 22():15330338221145994. PubMed ID: 36707056
[No Abstract] [Full Text] [Related]
11. The Role of D-3-Phosphoglycerate Dehydrogenase in Cancer.
Zhao X; Fu J; Du J; Xu W
Int J Biol Sci; 2020; 16(9):1495-1506. PubMed ID: 32226297
[TBL] [Abstract][Full Text] [Related]
12. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer.
Possemato R; Marks KM; Shaul YD; Pacold ME; Kim D; Birsoy K; Sethumadhavan S; Woo HK; Jang HG; Jha AK; Chen WW; Barrett FG; Stransky N; Tsun ZY; Cowley GS; Barretina J; Kalaany NY; Hsu PP; Ottina K; Chan AM; Yuan B; Garraway LA; Root DE; Mino-Kenudson M; Brachtel EF; Driggers EM; Sabatini DM
Nature; 2011 Aug; 476(7360):346-50. PubMed ID: 21760589
[TBL] [Abstract][Full Text] [Related]
13. Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression.
Liu J; Zhang C; Wu H; Sun XX; Li Y; Huang S; Yue X; Lu SE; Shen Z; Su X; White E; Haffty BG; Hu W; Feng Z
J Clin Invest; 2020 Jun; 130(6):3253-3269. PubMed ID: 32478681
[TBL] [Abstract][Full Text] [Related]
14. ASS1 inhibits triple-negative breast cancer by regulating PHGDH stability and de novo serine synthesis.
Luo W; Zou Z; Nie Y; Luo J; Ming Z; Hu X; Luo T; Ouyang M; Liu M; Tang H; Xie Y; Peng K; Chen L; Zhou J; Luo Z
Cell Death Dis; 2024 May; 15(5):319. PubMed ID: 38710705
[TBL] [Abstract][Full Text] [Related]
15. EWS-FLI1-regulated Serine Synthesis and Exogenous Serine are Necessary for Ewing Sarcoma Cellular Proliferation and Tumor Growth.
Issaq SH; Mendoza A; Kidner R; Rosales TI; Duveau DY; Heske CM; Rohde JM; Boxer MB; Thomas CJ; DeBerardinis RJ; Helman LJ
Mol Cancer Ther; 2020 Jul; 19(7):1520-1529. PubMed ID: 32371575
[TBL] [Abstract][Full Text] [Related]
16. Serine Synthesis via PHGDH Is Essential for Heme Production in Endothelial Cells.
Vandekeere S; Dubois C; Kalucka J; Sullivan MR; García-Caballero M; Goveia J; Chen R; Diehl FF; Bar-Lev L; Souffreau J; Pircher A; Kumar S; Vinckier S; Hirabayashi Y; Furuya S; Schoonjans L; Eelen G; Ghesquière B; Keshet E; Li X; Vander Heiden MG; Dewerchin M; Carmeliet P
Cell Metab; 2018 Oct; 28(4):573-587.e13. PubMed ID: 30017355
[TBL] [Abstract][Full Text] [Related]
17. New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming.
Colyn L; Alvarez-Sola G; Latasa MU; Uriarte I; Herranz JM; Arechederra M; Vlachogiannis G; Rae C; Pineda-Lucena A; Casadei-Gardini A; Pedica F; Aldrighetti L; López-López A; López-Gonzálvez A; Barbas C; Ciordia S; Van Liempd SM; Falcón-Pérez JM; Urman J; Sangro B; Vicent S; Iraburu MJ; Prosper F; Nelson LJ; Banales JM; Martinez-Chantar ML; Marin JJG; Braconi C; Trautwein C; Corrales FJ; Cubero FJ; Berasain C; Fernandez-Barrena MG; Avila MA
J Exp Clin Cancer Res; 2022 May; 41(1):183. PubMed ID: 35619118
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of the 3-phosphoglycerate dehydrogenase gene in mice: changes in gene expression and associated regulatory networks resulting from serine deficiency.
Furuya S; Yoshida K; Kawakami Y; Yang JH; Sayano T; Azuma N; Tanaka H; Kuhara S; Hirabayashi Y
Funct Integr Genomics; 2008 Aug; 8(3):235-49. PubMed ID: 18228065
[TBL] [Abstract][Full Text] [Related]
19. Rational Design of Selective Allosteric Inhibitors of PHGDH and Serine Synthesis with Anti-tumor Activity.
Wang Q; Liberti MV; Liu P; Deng X; Liu Y; Locasale JW; Lai L
Cell Chem Biol; 2017 Jan; 24(1):55-65. PubMed ID: 28042046
[TBL] [Abstract][Full Text] [Related]
20. 3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment.
Li M; Wu C; Yang Y; Zheng M; Yu S; Wang J; Chen L; Li H
Cell Oncol (Dordr); 2021 Jun; 44(3):541-556. PubMed ID: 33735398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]